Determination of the maximum tolerated dose of intranasal sufentanil and midazolam in Chinese: A pilot study
Acta Anaesthesiologica Scandinavica Apr 11, 2018
Zou Y, et al. - Researchers investigated the maximum tolerated dose (MTD, the dose of causing 10% respiratory depression) of intranasal sufentanil (SUF) and midazolam (MID) for sedation in thirty Chinese patients (18–65 years old) scheduled for gastroscopy, using continual reassessment method (CRM). The dose of MID (5 mg) was fixed, while the dose of SUF was increased progressively (six incremental doses ranging from 0–0.60 μg/kg). Based on CRM, 5 mg MID + 0.4 μg/kg SUF was defined as the MTD of intranasal MID and SUF for sedation during gastroscopy causing 10% respiratory depression.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries